Since DSC3 protein expression is not seen in all samples of bladder cancer and DSC3 gene expression has a wider range (0-46509 RSEM), we evaluated the effect of DSC3 enrichment on tumor-infiltrating immune cell signature genes by analyzing TCIG and TPIG in the samples with DSC3 expression in the upper quartile (DSC3 enriched cohort) of all DSC3-expressing samples (whole cohort). This evidence concerns the gene DSC3 and urinary bladder carcinoma.